Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial
Clinical trial NCT06750952 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06750952
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-20
- Primary completion
- 2026-12-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.